DISALCID Trademark

Trademark Overview

On Tuesday, April 19, 2022, a trademark application was filed for DISALCID with the United States Patent and Trademark Office. The USPTO has given the DISALCID trademark a serial number of 97370152. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, August 15, 2024. This trademark is owned by Oliva Therapeutics, LLC. The DISALCID trademark is filed in the Pharmaceutical Products category with the following description:

anti-inflammatory analgesic pharmaceutical preparation
disalcid

General Information

Serial Number97370152
Word MarkDISALCID
Filing DateTuesday, April 19, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, August 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements

Goods and Servicesanti-inflammatory analgesic pharmaceutical preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOliva Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRidgewood, NJ 07450
Party NameOliva Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRidgewood, NJ 07450

Trademark Events

Event DateEvent Description
Wednesday, February 8, 2023EXAMINERS AMENDMENT E-MAILED
Friday, April 22, 2022NEW APPLICATION ENTERED
Tuesday, April 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 6, 2023ASSIGNED TO EXAMINER
Wednesday, February 8, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 8, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 8, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, July 23, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 12, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Thursday, August 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 15, 2024SOU EXTENSION 2 GRANTED
Thursday, August 15, 2024SOU EXTENSION 2 FILED

Related Keywords

disalcid preparation pharmaceutical analgesic inflammatory anti